started · updated
Medical and agricultural developments reported in Italy
Experts from the Italian Society of Allergology, Asthma and Clinical Immunology (Siaaic) discussed advancements in treating severe asthma during their national congress in Salerno. Biological drugs are improving disease management by reducing the need for systemic cortisone and requiring fewer administrations. While high costs remain a barrier to access, the introduction of the first biosimilar for respiratory diseases offers a more affordable option. This drug is reimbursable in Italy and has recently received FDA approval for interchangeability in the United States.
In the agricultural sector, FederBio has called for continued support for organic farming in the upcoming Common Agricultural Policy (PAC) programming. Italy aims to have 25% of its agricultural land dedicated to organic methods by 2027, three years ahead of the European Union's 2030 target. FederBio President Maria Grazia Mammuccini emphasized the need to support small and medium-sized organic enterprises, invest in local production districts, and ensure strategic funding for research and innovation to maintain the sector's momentum.
Entities
FederBio · Italy · Maria Grazia Mammuccini · Società Italiana di Allergologia, Asma e Immunologia Clinica · Vincenzo Patella